Ardent Health (NYSE:ARDT) Price Target Cut to $12.00 by Analysts at Royal Bank Of Canada

Ardent Health (NYSE:ARDT) had its price objective reduced by Royal Bank Of Canada from $13.00 to $12.00 in a research report report published on Thursday morning,Benzinga reports. They currently have an outperform rating on the stock.

ARDT has been the topic of a number of other reports. Weiss Ratings restated a “sell (d+)” rating on shares of Ardent Health in a research note on Friday, June 12th. Wall Street Zen upgraded shares of Ardent Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 16th. Zacks Research raised shares of Ardent Health from a “strong sell” rating to a “hold” rating in a report on Wednesday, March 25th. Finally, UBS Group upped their target price on shares of Ardent Health from $13.00 to $13.50 and gave the stock a “buy” rating in a research report on Thursday, May 7th. Seven equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Ardent Health currently has a consensus rating of “Hold” and a consensus price target of $14.12.

Ardent Health Trading Down 0.8%

Shares of Ardent Health stock opened at $10.07 on Thursday. The company’s 50-day moving average price is $9.59 and its 200-day moving average price is $9.25. The company has a current ratio of 2.12, a quick ratio of 2.00 and a debt-to-equity ratio of 0.62. Ardent Health has a 12-month low of $7.71 and a 12-month high of $15.48. The company has a market cap of $1.44 billion, a price-to-earnings ratio of 10.60, a PEG ratio of 2.29 and a beta of 0.76.

Ardent Health (NYSE:ARDT) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.28 EPS for the quarter, beating the consensus estimate of $0.18 by $0.10. Ardent Health had a net margin of 2.09% and a return on equity of 13.85%. The company had revenue of $1.60 billion during the quarter, compared to analysts’ expectations of $1.58 billion. Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. On average, equities analysts expect that Ardent Health will post 1.11 earnings per share for the current fiscal year.

Insider Activity

In related news, CFO Alfred Lumsdaine acquired 10,000 shares of Ardent Health stock in a transaction dated Friday, June 5th. The shares were purchased at an average cost of $8.81 per share, with a total value of $88,100.00. Following the completion of the purchase, the chief financial officer owned 329,183 shares of the company’s stock, valued at $2,900,102.23. This represents a 3.13% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 1.90% of the company’s stock.

Hedge Funds Weigh In On Ardent Health

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Goldentree Asset Management LP lifted its position in Ardent Health by 99.7% in the fourth quarter. Goldentree Asset Management LP now owns 2,303,113 shares of the company’s stock valued at $20,302,000 after purchasing an additional 1,150,000 shares during the last quarter. Goldman Sachs Group Inc. boosted its position in Ardent Health by 1,684.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock valued at $10,558,000 after buying an additional 724,841 shares during the period. Ameriprise Financial Inc. increased its position in shares of Ardent Health by 75.6% in the second quarter. Ameriprise Financial Inc. now owns 1,634,822 shares of the company’s stock valued at $22,332,000 after acquiring an additional 703,739 shares during the period. Bridgeway Capital Management LLC raised its stake in shares of Ardent Health by 108.2% during the fourth quarter. Bridgeway Capital Management LLC now owns 946,571 shares of the company’s stock valued at $8,358,000 after acquiring an additional 491,961 shares during the last quarter. Finally, Hotchkis & Wiley Capital Management LLC purchased a new stake in shares of Ardent Health during the third quarter worth about $6,377,000.

About Ardent Health

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.